Cash Flow Hamlet BioPharma AB Cash flow Statement
Figures in Million
Consolidated Cash Flow Results
Jun'24
Jun'23
Jun'22
Jun'21
Jun'20
Jun'19
No of Months
12
12
12
12
12
12
Profit Before Tax
-41.00
-20.00
-17.00
-7.00
-23.00
-17.00
Adjustment
0.00
0.00
0.00
0.00
0.00
0.00
Changes In working Capital
-2.00
0.00
-3.00
1.00
0.00
1.00
Cash Flow after changes in Working Capital
0.00
0.00
0.00
0.00
0.00
0.00
Cash Flow from Operating Activities
-36.00
-19.00
-20.00
-5.00
-23.00
-15.00
Cash Flow from Investing Activities
0.00
-9.00
0.00
0.00
0.00
0.00
Cash Flow from Financing Activities
40.00
8.00
52.00
0.00
25.00
10.00
Net Cash Inflow / Outflow
4.00
-21.00
32.00
-5.00
2.00
-4.00
Opening Cash & Cash Equivalents
0.00
0.00
0.00
0.00
0.00
0.00
Cash & Cash Equivalent on Amalgamation / Take over / Merger
0.00
0.00
0.00
0.00
0.00
0.00
Cash & Cash Equivalent of Subsidiaries under liquidations
0.00
0.00
0.00
0.00
0.00
0.00
Translation adjustment on reserves / op cash balances foreign subsidiaries
0.00
0.00
0.00
0.00
0.00
0.00
Effect of Foreign Exchange Fluctuations
0.00
0.00
0.00
0.00
0.00
0.00
Closing Cash & Cash Equivalent
0.00
0.00
0.00
0.00
0.00
0.00
Figures in SEK Million
Seasonal companies are compared with the same quarter last year
Seasonal companies are compared with the same quarter last year
Compare Cash Flow Results of Hamlet BioPharma AB
Figures in Million
consolidated Cash Flow Results
Change(SEK)
Change(%)
Profit Before Tax
-41.816661
-89.954
48.00
53.51%
Adjustment
0
0
0.00
0.00%
Changes In working Capital
-2.018542
-16.476
14.00
87.75%
Cash Flow after changes in Working Capital
0
0
0.00
0.00%
Cash Flow from Operating Activities
-36.002089
-102.84
66.00
64.99%
Cash Flow from Investing Activities
-0.278085
-1.187
1.00
76.57%
Cash Flow from Financing Activities
40.988397
78.932
-38.00
-48.07%
Net Cash Inflow / Outflow
4.708224
-24.994
28.00
118.84%
Opening Cash & Cash Equivalents
0
0
0.00
0.00%
Cash & Cash Equivalent on Amalgamation / Take over / Merger
0
0
0.00
0.00%
Cash & Cash Equivalent of Subsidiaries under liquidations
0
0
0.00
0.00%
Translation adjustment on reserves / op cash balances foreign subsidiaries
0
0
0.00
0.00%
Effect of Foreign Exchange Fluctuations
0
0.101
0.00
-100.00%
Closing Cash & Cash Equivalent
0
0
0.00
0.00%
Cash Flow - Snapshot (Consolidated) - Jun'24
YoY Growth in year ended Jun 2024 is -83.56% vs 3.46% in Jun 2023
Jun'24
Jun'23
Change(%)
Cash Flow from Operating Activities
-36.00
-19.61
-83.56%
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."
